Maloir Quentin, Petitjean Hélène, Parzibut Gilles, Weber Thierry, Davidsen Cedric, Dulgheru Elena, Lancellotti Patrizio, Louis Renaud, Guiot Julien, Humbert Marc
Service de Pneumologie, CHU Liège, Belgique.
Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Bicêtre - Assistance Publique Hôpitaux de Paris, Université Paris-Saclay, INSERM, France.
Rev Med Liege. 2023 Feb;78(2):99-106.
Pulmonary hypertension (PH) is a common clinical condition linked to chronic cardiopulmonary illnesses. It must be distinguished from pulmonary arterial hypertension (PAH), a rare disease characterized by a specific involvement of the pulmonary arterial bed. An early diagnosis and accurate classification by a multidisciplinary team are necessary for a multimodal and individualized therapy approach. This article aims to provide a summary of the most recent ESC/ERS recommendations published in 2022.
肺动脉高压（PH）是一种与慢性心肺疾病相关的常见临床病症。它必须与肺动脉高压（PAH）相区分，PAH是一种罕见疾病，其特征是肺动脉床有特定累及。多学科团队进行早期诊断和准确分类对于多模式个体化治疗方法是必要的。本文旨在总结2022年发布的最新ESC/ERS指南。
